/
We are a leading provider of health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, inform…
12.49% operating margin is respectable but not wide. ROIC at 3.03%. Suggests the business covers its cost of capital, but doesn't point to a wide moat.
Revenue grew 3.7%, steady but not accelerating.
Net debt of $2.48B represents 4.9x FCF, leverage limits flexibility.
Profitability & Returns
Revenue (TTM)
$2.90B
▲ +3.7% YoY
Net Income (TTM)
$240M
▼ -10.8% YoY
Op. Margin
12.41%
ROIC
3.11%
▲ +0.3pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$493M
▼ -6.0% YoY
Op. Cash Flow (TTM)
$570M
▼ -7.2% YoY
Net Debt
$2.49B
Cash & Equiv.
$860M
5Y CAGR: -5.5%
5Y CAGR: -9.3%
Continue Research